Keita Pharma

India
Manufacture and export of pharmaceuticals, including injections and nutraceuticals, in India.

About Keita Pharma

Keita Pharma is a Healthcare company based in India. Manufacture and export of pharmaceuticals, including injections and nutraceuticals, in India. Its Indian entity Keita Pharma Private Limited reported revenue of β‚Ή8.51 Cr. Keita Pharma offers products and services including Oncology Injections and Nutraceuticals. Its focus areas include Nutraceuticals, Supplements Production, Nutritional Products and Pharmaceuticals.

Company details

Keita Pharma is recognized for its involvement in the manufacture of various pharmaceutical products, such as anti-cancer drugs, antibiotics, and cardiac care medications, which are exported globally. Products are categorized into injections, IV fluids, eye drops, and nutraceuticals to address diverse healthcare demands. Operations are conducted from a facility in Navi Mumbai, India, where quality formulations are produced for international markets. The company supports sectors like obstetrics and steroids, ensuring products meet required standards. Overall, pharmaceutical exports and manufacturing processes are managed efficiently to fulfill consumer needs.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website keitapharma.com
  • Legal Name Keita Pharma Pvt. Ltd
  • Date of Incorporation 06 Dec, 2010
  • Jurisdiction Navi Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹8.51 Cr

    FY 2025 · +55% YoY

  • Net Profit
    ₹52.9 Lakh

    FY 2025 · 6% margin

  • EBITDA
    ₹73.4 Lakh

    FY 2025 · 9% margin

Products & Services of Keita Pharma

Keita Pharma offers a comprehensive portfolio of products and services, including Oncology Injections and Nutraceuticals.

Oncology Injections
Pharmaceuticals

Liquid and lyophilized oncology injections are manufactured for cancer treatment purposes

Nutraceuticals
Health Supplements

Nutraceutical products such as capsules and syrups are produced to meet nutritional and health support needs

Board of directors of Keita Pharma Private Limited (Keita Pharma)

Keita Pharma Private Limited is the primary company behind Keita Pharma. The board of Keita Pharma Private Limited currently have 2 directors; the longest-serving is Dinesh Baliram Gursale, appointed in 2010. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Dinesh Baliram Gursale
DIN 03181518
Director06 Dec 201015 yrs 11 moKeita Pharma Private Limited
Poonam Dinesh Gursale
DIN 07587451
Director10 Aug 201610 yrs 3 moKeita Pharma Private Limited

Financials of Keita Pharma

Figures of Keita Pharma Private Limited, the primary company behind Keita Pharma, for FY 2025. Revenue was ₹8.51 Cr (+55% year on year). Net profit was ₹52.9 Lakh (6% margin). EBITDA was ₹73.4 Lakh (9% margin). Revenue has grown at a compounded annual rate of -10% over three years and +22% over five years.

  • ₹8.51 CrRevenue · FY 2025 · +55% YoY
  • ₹52.9 LakhNet profit · 6% margin
  • ₹73.4 LakhEBITDA · 9% margin
  • ₹1 LakhPaid-up capital
  • -10%Revenue CAGR, 3 years
  • +22%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Keita Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Keita Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as Keita Pharma (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 55.41 M362
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 56.21 M144
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Keita Pharma

Keita Pharma is headquartered in India.

The primary company behind Keita Pharma, Keita Pharma Private Limited, reported revenue of β‚Ή8.51 Cr for FY 2025, up 55% year on year.

Keita Pharma is recognized for its involvement in the manufacture of various pharmaceutical products, such as anti-cancer drugs, antibiotics, and cardiac care medications, which are exported globally. Products are categorized into injections, IV fluids, eye drops, and nutraceuticals to address diverse healthcare demands. Operations are conducted from a facility in Navi Mumbai, India, where quality formulations are produced for international markets. The company supports sectors like obstetrics and steroids, ensuring products meet required standards. Overall, pharmaceutical exports and manufacturing processes are managed efficiently to fulfill consumer needs.

Keita Pharma offers Oncology Injections and Nutraceuticals.

Keita Pharma operates through Keita Pharma Private Limited.

The legal entities of Keita Pharma currently have 2 directors, including Dinesh Baliram Gursale, Poonam Dinesh Gursale.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available